Shutterstock A recent study of men with early-stage prostate cancer found no difference in 10-year death rates, regardless of whether their doctors actively monitored the cancers for signs of growth or eradicated the men’s cancers with surgery or radiation. What does this study mean for patients? Based on research we have conducted [...]
A new study confirms that active surveillance is a safe and reasonable alternative to immediate treatment for prostate cancer. In recently published study that followed 1,300 men, the prostate cancer survival rate after 10-15 years ...
In the first study to compare active monitoring, surgery and radiation for prostate cancer, researchers found no differences in death rates
(Reuters Health) - Men who take hormone therapy for prostate cancer may have a higher risk of dementia than patients who receive different treatment for these malignancies, a U.S. study suggests.
A 10-year study of more than 1,500 men with prostate cancer found no difference in death rates between men who had surgery or radiation and those who monitored the disease.